Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans

CONTEXT: In 2005, HEDIS introduced a quality measure to assess the receipt of disease modifying anti-rheumatic drugs (DMARDs) among patients with rheumatoid arthritis (RA). OBJECTIVE: To identify sociodemographic, community, and health-plan factors associated with DMARD receipt among Medicare manage...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Schmajuk, Gabriela, Trivedi, Amal, Solomon, Daniel, Yelin, Edward, Trupin, Laura, Chakravarty, Eliza, Yazdany, Jinoos
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3172813/
https://ncbi.nlm.nih.gov/pubmed/21285425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2011.67
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller